
Dishman Carbogen Amcis Limited – NSE:DCAL.NS
Dishman Carbogen Amcis Limited stock price today
Dishman Carbogen Amcis Limited stock price monthly change
Dishman Carbogen Amcis Limited stock price quarterly change
Dishman Carbogen Amcis Limited stock price yearly change
Dishman Carbogen Amcis Limited key metrics
Market Cap | 41.99B |
Enterprise value | 39.51B |
P/E | -548.33 |
EV/Sales | 1.67 |
EV/EBITDA | 12.60 |
Price/Sales | 0.87 |
Price/Book | 0.37 |
PEG ratio | -4.94 |
EPS | -9.79 |
Revenue | 26.15B |
EBITDA | 3.77B |
Income | -1.53B |
Revenue Q/Q | 5.84% |
Revenue Y/Y | 8.40% |
Profit margin | -0.15% |
Oper. margin | 0.59% |
Gross margin | 79.7% |
EBIT margin | 0.59% |
EBITDA margin | 14.45% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeDishman Carbogen Amcis Limited stock price history
Dishman Carbogen Amcis Limited stock forecast
Dishman Carbogen Amcis Limited financial statements
Jun 2023 | 7.23B | 170M | 2.35% |
---|---|---|---|
Sep 2023 | 5.86B | -409M | -6.97% |
Dec 2023 | 6.51B | -596.3M | -9.16% |
Mar 2024 | 6.54B | -699.2M | -10.68% |
Payout ratio | 0% |
---|
2016 | 1.19% |
---|---|
2017 | 0.42% |
2019 | |
2020 | 0.38% |
2022 |
Jun 2023 | 0 | 0 | |
---|---|---|---|
Sep 2023 | 95011200000 | 37.30B | 39.26% |
Dec 2023 | 0 | 0 | |
Mar 2024 | 95814100000 | 39.53B | 41.27% |
Mar 2023 | 1.51B | 0 | 0 |
---|---|---|---|
Jun 2023 | 1.40B | 0 | 0 |
Sep 2023 | 1.50B | 0 | 0 |
Dec 2023 | 1.60B | 0 | 0 |
Dishman Carbogen Amcis Limited alternative data
Aug 2023 | 1,168 |
---|---|
Sep 2023 | 1,168 |
Oct 2023 | 1,295 |
Nov 2023 | 1,295 |
Dec 2023 | 1,295 |
Jan 2024 | 1,295 |
Feb 2024 | 1,295 |
Mar 2024 | 1,295 |
Apr 2024 | 1,295 |
May 2024 | 1,295 |
Jun 2024 | 1,295 |
Jul 2024 | 1,295 |
Dishman Carbogen Amcis Limited other data
-
What's the price of Dishman Carbogen Amcis Limited stock today?
One share of Dishman Carbogen Amcis Limited stock can currently be purchased for approximately $205.65.
-
When is Dishman Carbogen Amcis Limited's next earnings date?
Unfortunately, Dishman Carbogen Amcis Limited's (DCAL.NS) next earnings date is currently unknown.
-
Does Dishman Carbogen Amcis Limited pay dividends?
No, Dishman Carbogen Amcis Limited does not pay dividends.
-
How much money does Dishman Carbogen Amcis Limited make?
Dishman Carbogen Amcis Limited has a market capitalization of 41.99B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 18.82% to 25.44B US dollars.
-
What is Dishman Carbogen Amcis Limited's stock symbol?
Dishman Carbogen Amcis Limited is traded on the NSE under the ticker symbol "DCAL.NS".
-
What is Dishman Carbogen Amcis Limited's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Dishman Carbogen Amcis Limited?
Shares of Dishman Carbogen Amcis Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Dishman Carbogen Amcis Limited have?
As Jul 2024, Dishman Carbogen Amcis Limited employs 1,295 workers.
-
When Dishman Carbogen Amcis Limited went public?
Dishman Carbogen Amcis Limited is publicly traded company for more then 21 years since IPO on 22 Apr 2004.
-
What is Dishman Carbogen Amcis Limited's official website?
The official website for Dishman Carbogen Amcis Limited is imdcal.com.
-
How can i contact Dishman Carbogen Amcis Limited?
Dishman Carbogen Amcis Limited can be reached via phone at +91 2717 420 100.
Dishman Carbogen Amcis Limited company profile:

Dishman Carbogen Amcis Limited
imdcal.comNSE
1,132
Biotechnology
Healthcare
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, intermediates, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitisers, antiseptics, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was incorporated in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
Ahmedabad, 380058
:
ISIN: INE385W01011
CUSIP: Y1R03Y104